ACADIA Pharmaceuticals Guides Fiscal 2026 Revenue to $760 Million to $775 Million on Nov. 4

ACADIA Pharmaceuticals set initial fiscal 2026 revenue guidance of $760 million to $775 million. Related Stocks: ACAD ,

Read original article